ArticleNPJ vaccines2026

Preclinical development of a cross-protective β-SARS-CoV-2 virus-like particle vaccine adjuvanted with MF59.

Linda Earnest et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.